阿拉丁(688179) - 阿拉丁接待投资者调研活动记录（2024年11月8日-11月12日）

Group 1: Company Financial Performance - The company's gross profit margin remains stable, indicating no impact from price wars on product pricing [1] - In the first three quarters of 2023, the growth rate of the company's expenses was only 4.3%, lower than the revenue growth rate, ensuring net profit growth [2] - The company maintains a low debt ratio and minimal financial expenses, contributing to controllable expense ratios [2] Group 2: Overseas Business Development - Aladdin plans to acquire 100% equity of UNA 589 Equity Management GmbH for €28,500 to expand its business in Germany and Europe [3] - The company intends to increase its investment in neoLab Migge GmbH by €888,900 to establish a stable long-term distributor relationship in Germany and Europe [3] - Orders from overseas markets are beginning to materialize as the company continues to stock up for international sales [4] Group 3: Industry Trends and Research Impact - The recovery of normal teaching and research activities in universities has led to an increase in demand, with a notable rise in graduate student numbers [5] - Aladdin's products have been cited in a total of 198,752 SCI papers, with an average impact factor of 6.12, indicating strong influence in laboratory settings [5] - The number of new papers citing Aladdin's products has consistently exceeded 30,000 annually, with 33,766 in 2022 and 35,890 in 2023, showcasing significant growth compared to peers [5] Group 4: Disclosure of Major Information - The investor meeting did not involve any major information that needs to be disclosed [5]